Literature DB >> 11159570

Hepatitis associated with Kava, a herbal remedy for anxiety.

M Escher1, J Desmeules, E Giostra, G Mentha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11159570      PMCID： PMC26591          DOI： 10.1136/bmj.322.7279.139

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Fatal hepatitis after herbal tea.

Authors:  N Mostefa-Kara; A Pauwels; E Pines; M Biour; V G Levy
Journal:  Lancet       Date:  1992-09-12       Impact factor: 79.321

2.  Chinese herbal medicine, fulminant hepatitis, and liver transplantation.

Authors:  E M Yoshida; C A McLean; E S Cheng; P D Blanc; K A Somberg; L D Ferrell; J R Lake
Journal:  Am J Gastroenterol       Date:  1996-12       Impact factor: 10.864

3.  Chaparral-associated hepatotoxicity.

Authors:  N M Sheikh; R M Philen; L A Love
Journal:  Arch Intern Med       Date:  1997-04-28

4.  Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community.

Authors:  J D Mathews; M D Riley; L Fejo; E Munoz; N R Milns; I D Gardner; J R Powers; E Ganygulpa; B J Gununuwawuy
Journal:  Med J Aust       Date:  1988-06-06       Impact factor: 7.738

5.  [Necrotizing hepatitis after taking herbal remedies].

Authors:  S Strahl; V Ehret; H H Dahm; K P Maier
Journal:  Dtsch Med Wochenschr       Date:  1998-11-20       Impact factor: 0.628
  5 in total
  21 in total

Review 1.  Complementary alternative medicine and nuclear medicine.

Authors:  Ursula Werneke; V Ralph McCready
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-14       Impact factor: 9.236

2.  Regulating herbal medicines in the UK.

Authors:  Robin E Ferner; Keith Beard
Journal:  BMJ       Date:  2005-07-09

Review 3.  Therapeutic potential of kava in the treatment of anxiety disorders.

Authors:  Yadhu N Singh; Nirbhay N Singh
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  A systematic review of the safety of kava extract in the treatment of anxiety.

Authors:  Clare Stevinson; Alyson Huntley; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

6.  Influence of kavain on hepatic ultrastructure.

Authors:  Shuang Fu; Emine Korkmaz; Filip Braet; Quan Ngo; Iqbal Ramzan
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

7.  Anticonvulsant and anxiolytic-like effects of compounds isolated from Polygala sabulosa (Polygalaceae) in rodents: in vitro and in vivo interactions with benzodiazepine binding sites.

Authors:  Filipe Silveira Duarte; Mariel Marder; Alexandre Ademar Hoeller; Marcelo Duzzioni; Beatriz Garcia Mendes; Moacir Geraldo Pizzolatti; Thereza Christina Monteiro De Lima
Journal:  Psychopharmacology (Berl)       Date:  2007-12-22       Impact factor: 4.530

Review 8.  Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements.

Authors:  Lily Dara; Jennifer Hewett; Joseph Kartaik Lim
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 9.  Toxicity of kava kava.

Authors:  Peter P Fu; Qingsu Xia; Lei Guo; Hongtao Yu; Po-Chuen Chan
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2008 Jan-Mar       Impact factor: 3.781

Review 10.  Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps.

Authors:  Rolf Teschke; Axel Eickhoff
Journal:  Front Pharmacol       Date:  2015-04-23       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.